Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma

Leonardo Mirandola; Yuefei Yu; Kitty Chui; Marjorie R. Jenkins; Everardo Cobos; Constance M. John; Maurizio Chiriva-Internati

doi:10.1371/journal.pone.0021811

Loading metrics

Open Access

Peer-reviewed

Research Article

Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma

Leonardo Mirandola ,

Contributed equally to this work with: Leonardo Mirandola, Yuefei Yu

Affiliations Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas, United States of America, Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America
⨯
Yuefei Yu ,

Contributed equally to this work with: Leonardo Mirandola, Yuefei Yu

Affiliation Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas, United States of America
⨯
Kitty Chui,

Affiliation MandalMed, San Francisco, California, United States of America
⨯
Marjorie R. Jenkins,

Affiliations Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas, United States of America, Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America
⨯
Everardo Cobos,

Affiliations Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas, United States of America, Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America
⨯
Constance M. John,

Affiliation MandalMed, San Francisco, California, United States of America
⨯
Maurizio Chiriva-Internati

* E-mail: maurizio.chiriva@ttuhsc.edu

Affiliations Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas, United States of America, Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, United States of America
⨯

Galectin-3C Inhibits Tumor Growth and Increases the Anticancer Activity of Bortezomib in a Murine Model of Human Multiple Myeloma

Leonardo Mirandola,
Yuefei Yu,
Kitty Chui,
Marjorie R. Jenkins,
Everardo Cobos,
Constance M. John,
Maurizio Chiriva-Internati

Published: July 13, 2011
https://doi.org/10.1371/journal.pone.0021811

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Angiogenesis
Is the Subject Area "Angiogenesis" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Chemotaxis assay
Is the Subject Area "Chemotaxis assay" applicable to this article?

Thanks for your feedback.